TMDX: TransMedics Group, Inc. Common Stock Company Profile & Statistics

TransMedics Group, Inc. Common Stock Profile

About

TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation. TransMedics Inc. is headquartered in Andover, Massachusetts.

Info & Links

CEO

Waleed H. Hassanein

Headquarters

200 MINUTEMAN ROAD
ANDOVER, MA 01810, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

728

TransMedics Group, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

4.43B

Enterprise Value

4.47B

Enterprise Value/EBITDA(ttm)

36.87

Price to Earnings Ratio(ttm)

53.26

Price to Sales(ttm)

7.94

Price to Book(mrq)

12.66

Price to Cash(ytd)

79.94

Profitability

Gross Margin(ttm)

60.21%

Operating Margin(ttm)

16.20%

Profit Margin(ttm)

15.66%

Return on Equity(ttm)

31.42%

Return on Invested Capital(ttm)

11.27%

Return on Assets(ttm)

10.55%

Income Statement

Revenue(ttm)

566.35M

Revenue Per Share(ttm)

16.57

Gross Profit(ttm)

341.40M

EBITDA(ttm)³

121.35M

Net Income Available to Common(ttm)

91.77M

Diluted EPS(ttm)

2.47

Share Statistics

Beta (5Y Monthly)

2.08

52-Week Change

60.48%

S&P 500 52-Week Change

19.74%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

34.17M

Dividend Yield

0.00%

Float⁴

31.78M

% Held by Insiders

7.00%

% Held by Institutions

99.67%

Balance Sheet

Total Cash(mrq)

466.17M

Total Cash Per Share(mrq)

13.64

Total Debt(mrq)

511.69M

Total Debt/Equity(mrq)

144.06%

Current Ratio(mrq)

7.69%

Quick Ratio(mrq)

9.17%

Book Value Per Share(mrq)

10.40

Cash Flow

Operating Cash Flow Per Share(ytd)

3.89

Free Cash Flow(ytd)

114.59M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

TMDX

TransMedics Group, Inc. Common Stock